Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Post Office vs. FedEx?

This article was originally published in RPM Report

Executive Summary

One idea the Democrats have for reforming Part D is launching a Medicare-run prescription drug plan. The proposal underscores how much ground Big Pharma has gained since the Medicare debate began.

You may also be interested in...



Big Stakes for Big Pharma in the Push Towards Full Enrollment in Part D

There are 4 million Medicare beneficiaries who have not yet joined the new drug benefit. The more who sign up in 2007, the better for Big Pharma.

Negotiating Price Negotiation: Why the Democrats Will Struggle to Pressure Part D Prices

The new Congress wants to make federal price negotiation under Medicare a reality. But it won't be easy. Big Pharma should expect plenty of interference from the Democrats in Part D, but it is hard to see a meaningful impact on prices in the near term.

Negotiating Price Negotiation: Why the Democrats Will Struggle to Pressure Part D Prices

The new Congress wants to make federal price negotiation under Medicare a reality. But it won't be easy. Big Pharma should expect plenty of interference from the Democrats in Part D, but it is hard to see a meaningful impact on prices in the near term.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS080006

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel